Molecular Determinants of Ligand-Induced Allosteric Coupling to Gq and Gi at the Angiotensin II Type 1 Receptor
Publication
, Conference
Acheampong, A; Wingler, LM; Feld, A; Collins, M; Small, B
Published in: The Journal of Pharmacology and Experimental Therapeutics
June 2023
Duke Scholars
Published In
The Journal of Pharmacology and Experimental Therapeutics
DOI
ISSN
0022-3565
Publication Date
June 2023
Volume
385
Start / End Page
149 / 149
Publisher
Elsevier BV
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Acheampong, A., Wingler, L. M., Feld, A., Collins, M., & Small, B. (2023). Molecular Determinants of Ligand-Induced Allosteric Coupling to Gq and Gi at the Angiotensin II Type 1 Receptor. In The Journal of Pharmacology and Experimental Therapeutics (Vol. 385, pp. 149–149). Elsevier BV. https://doi.org/10.1124/jpet.122.254730
Acheampong, Akua, Laura M. Wingler, Andrew Feld, Matthew Collins, and Brandi Small. “Molecular Determinants of Ligand-Induced Allosteric Coupling to Gq and Gi at the Angiotensin II Type 1 Receptor.” In The Journal of Pharmacology and Experimental Therapeutics, 385:149–149. Elsevier BV, 2023. https://doi.org/10.1124/jpet.122.254730.
Acheampong A, Wingler LM, Feld A, Collins M, Small B. Molecular Determinants of Ligand-Induced Allosteric Coupling to Gq and Gi at the Angiotensin II Type 1 Receptor. In: The Journal of Pharmacology and Experimental Therapeutics. Elsevier BV; 2023. p. 149–149.
Acheampong, Akua, et al. “Molecular Determinants of Ligand-Induced Allosteric Coupling to Gq and Gi at the Angiotensin II Type 1 Receptor.” The Journal of Pharmacology and Experimental Therapeutics, vol. 385, Elsevier BV, 2023, pp. 149–149. Crossref, doi:10.1124/jpet.122.254730.
Acheampong A, Wingler LM, Feld A, Collins M, Small B. Molecular Determinants of Ligand-Induced Allosteric Coupling to Gq and Gi at the Angiotensin II Type 1 Receptor. The Journal of Pharmacology and Experimental Therapeutics. Elsevier BV; 2023. p. 149–149.
Published In
The Journal of Pharmacology and Experimental Therapeutics
DOI
ISSN
0022-3565
Publication Date
June 2023
Volume
385
Start / End Page
149 / 149
Publisher
Elsevier BV
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences